Results of the AML 12 trial
11 Dec 2017
Results of the AML 12 trial
Why we are not ready for personalised medicine
Genetically profiling entire populations, starting with Estonia
How does ancestry affect your health?
Neuroblastoma and cell communication networks
Personalised medicine differs from precision medicine
Approaches to screening and early detection across Europe
Connecting personalised medicine research in Canada with Europe
Roche joining forces to forward precision oncology
The reality of pancreatic cancer
Personalised medicine for inherited breast cancer
Lung cancer screening across Europe